Related Experiment Video
Updated: Jan 15, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
Published on: February 1, 2019
Improved Messenger RNA Stability and Biocompatibility Through Self-Gelatinizable Nucleic Acids
Takumi Tanifuji1, Kosuke Kusamori2, Chihiro Tanaka1
1Laboratory of Biopharmaceutics, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Katsushika, Tokyo, Japan.
Abstract:
Recent advances in the chemical synthesis and modification of messenger RNA (mRNA) have generated growing interest in mRNA-based therapeutics. However, the inherent instability of mRNA in vivo and during storage remains a major challenge, requiring the development of safe and effective delivery systems. Lipid nanoparticles (LNPs) currently serve as the primary vehicle for mRNA delivery, with well-documented clinical success. Nevertheless, immunogenicity associated with certain components underscores the need for biocompatible alternatives. To address these stability and safety concerns, we developed an mRNA-loaded DNA hydrogel based on self-gelatinizable nucleic acid technology. The hydrogel is formed through the self-assembly of designed DNA units and provides an inherently biocompatible framework. mRNA loaded into the hydrogel exhibited sustained protein expression in myofibroblasts due to controlled mRNA release, while inducing negligible proinflammatory cytokine production or cytotoxicity in antigen-presenting cells. Additionally, the hydrogel markedly enhanced mRNA resistance to both nuclease degradation and storage-induced degradation. These findings demonstrate that mRNA-loaded DNA hydrogels can serve as a promising, biocompatible platform for next-generation mRNA therapeutics, achieving both enhanced stability and reduced immunogenicity.
Related Concept Videos
RNA Stability
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

